New spinal anesthesia method could speed up recovery after joint replacement
NCT ID NCT06526156
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at using a smaller dose of a lighter-than-normal numbing medicine (hypobaric bupivacaine) injected into the lowest space in the spine for hip or knee replacement surgery. The goal is to see if this approach still works well for pain control during surgery while helping patients regain feeling and movement in their legs faster afterward. About 55 adults having elective hip or knee replacement at Toronto Western Hospital will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
55 people
The number who actually took part.
- Started
-
Jul 2024
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults aged at least 20 years having inpatient elective unilateral total hip or knee arthroplasty surgery
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients undergoing elective unilateral total hip or knee arthroplasty under spinal anesthesia at TWH who are scheduled for inpatient overnight admission * American Society of Anesthesiologists physical status class (ASA-PS) 1-3 * At least 20 years of age Exclusion Criteria: * Refusal to participate * Inability to communicate due to language barrier or cognitive impairment * Height \> 200 cm * Weight \>120 kg * Body mass index (BMI) \>45 kg/m\^2 * Contraindication or allergy to amide-type local anesthetic * Contraindication to spinal anesthesia at the L5-S1 space (e.g., infection at the injection site, existing coagulopathy, severe spinal stenosis at higher vertebral levels) * Previous spinal surgery in the lumbosacral spine * Spinal anesthesia performed in the operating room rather than the block room * Spinal anesthesia that includes administration of intrathecal opioids (e.g., morphine, fentanyl) * Pre-existing sensory or motor impairment in the lower extremities * Inability to identify the L5-S1 space with ultrasonography
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anesthesia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hip surgery pain targeted with nerve block in new trial
- Can a gentler anesthesia cocktail protect a child's developing brain?
- Lung imaging could reveal the best anesthetic dose for breast surgery
- Which monitor reads a Child's pain best during surgery?
- Propofol vs. inhaled anesthesia: which one spares your recovery?
- Which epidural technique best handles a cesarean emergency?